GLP1R and type 2 diabetes mellitus: Considering the overlapping hypoglycemic mechanisms, it is recommended to discontinue DPP-4i when T2DM patients are intensified from DPP-4i to GLP-1 RA (American Diabetes Association Professional Practice et al., 2022).